amiloride has been researched along with ADPKD in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arif Pavel, M; Campbell, T; Fung, HY; Holtzman, NG; Kashyap, P; Lam, C; Lv, C; Møller, SG; Ng, C; Valentino, V; Yang, L; Yu, Y; Zenisek, D | 1 |
| Fujiki, H; Nivens, E; Pinto, CS; Reif, GA; Wallace, DP; Yamaguchi, T | 1 |
| Bacallao, RL; Blacklock, BJ; Blazer-Yost, BL; Flaig, S; Gattone, VH | 1 |
3 other study(ies) available for amiloride and ADPKD
| Article | Year |
|---|---|
Function and regulation of TRPP2 ion channel revealed by a gain-of-function mutant.
Topics: Amiloride; Animals; Calcium; Gene Knockdown Techniques; Humans; Mutation; Point Mutation; Polycystic Kidney, Autosomal Dominant; Ruthenium Red; TRPP Cation Channels; Zebrafish | 2016 |
Tolvaptan inhibits ERK-dependent cell proliferation, Cl⁻ secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin.
Topics: Adult; Aged; Amiloride; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blotting, Western; Cell Proliferation; Cells, Cultured; Chlorides; Cyclic AMP; Cystic Fibrosis Transmembrane Conductance Regulator; Cysts; Diuretics; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Renal Agents; Tolvaptan; Vasopressins | 2011 |
Lysophosphatidic acid is a modulator of cyst growth in autosomal dominant polycystic kidney disease.
Topics: Amiloride; Cell Line; Chlorides; Cyst Fluid; Epithelial Cells; Humans; Ion Transport; Lysophospholipids; Polycystic Kidney, Autosomal Dominant; Receptors, Lysophosphatidic Acid; Sodium Channel Blockers | 2011 |